Aug 07, 2025
Elanco Animal Health Reports Second Quarter 2025 Results
Jun 05, 2025
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief
Mar 17, 2025
Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets
Feb 13, 2025
Elanco Reinforces Commitment to Veterinary and Pet Owner Education
Jan 23, 2025
Now Available: Credelio Quattro(TM) (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind
Nov 12, 2024
Elanco Strengthens Board of Directors with Addition of Stacey Ma
Nov 07, 2024
Elanco Animal Health Reports Third Quarter 2024 Results
Oct 07, 2024
Elanco Receives FDA Approval for Credelio Quattro(TM) (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose
Aug 20, 2024
Elanco Announces Credelio Quattro Moves to Final FDA Administrative Review
Aug 08, 2024
Elanco Animal Health Reports Second Quarter 2024 Results
Jun 27, 2024
Elanco Provides Innovation Update
Apr 01, 2024
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
Feb 29, 2024
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
Feb 08, 2019
Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health
Jan 25, 2018
Elanco Announces Global Agreement with Ab E Discovery for New Technology
Jan 22, 2018
Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio® (lotilaner) to Treat and Protect Against Ticks and Fleas
Jan 18, 2018
Elanco Innovations Named Best Products for 2017
Jan 16, 2018
Innventure and Elanco Announce Strategic Initiative to Commercialize Disruptive Technologies for Animal Health
Jan 11, 2018
Elanco, Aratana Announce Marketing Authorization of GALLIPRANT® (grapiprant tablets) in Europe
Nov 10, 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe